Secondary prevention.
D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D002170:Canada; D008078:Cholesterol, LDL / Q000097:blood; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000188:drug therapy / Q000517:prevention & control*; D003362:Cost-Benefit Analysis; D006801:Humans; D008329:Managed Care Programs; D017035:Pravastatin / Q000627:therapeutic use*; D012606:Scotland; D014481:United States
D000924:Anticholesteremic Agents; D008078:Cholesterol, LDL; D017035:Pravastatin